These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 576904)

  • 1. Benign breast disease and oral contraceptive use.
    Janerich DT; Glebatis DM; Dugan JM
    JAMA; 1977 May; 237(20):2199-201. PubMed ID: 576904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral contraceptives and reduced risk of benign breast diseases.
    Ory H; Cole P; MacMahon B; Hoover R
    N Engl J Med; 1976 Feb; 294(8):419-22. PubMed ID: 1246309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptives and benign breast disease.
    Hislop TG; Threlfall WJ
    Am J Epidemiol; 1984 Aug; 120(2):273-80. PubMed ID: 6465125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for benign breast disease.
    Brinton LA; Vessey MP; Flavel R; Yeates D
    Am J Epidemiol; 1981 Mar; 113(3):203-14. PubMed ID: 7468579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystic disease, family history of breast cancer, and use of oral contraceptives.
    Vakil DV; Elinson L; Morgan RW
    Cancer Detect Prev; 1981; 4(1-4):511-5. PubMed ID: 7349817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral contraceptive use and risk of breast cancer among women with a family history of breast cancer: a prospective cohort study.
    Silvera SA; Miller AB; Rohan TE
    Cancer Causes Control; 2005 Nov; 16(9):1059-63. PubMed ID: 16184471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term oral contraceptive use and the risk of breast cancer. The centers for Disease Control Cancer and Steroid Hormone Study.
    JAMA; 1983 Mar; 249(12):1591-5. PubMed ID: 6338262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of benign and malignant breast disorders in women taking hormones (contraceptive pill or hormonal replacement therapy).
    Tzingounis V; Cardamakis E; Ginopoulos P; Argiropoulos G
    Anticancer Res; 1996; 16(6C):3997-4000. PubMed ID: 9042326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From the NIH: Oral contraceptive use no protection against cancer risk-associated fibrocystic breast disease.
    JAMA; 1979 Jan; 241(1):24. PubMed ID: 758486
    [No Abstract]   [Full Text] [Related]  

  • 10. Epidemiology of benign breast lesions: lack of association with oral contraceptive use.
    Sartwell PE; Arthes FG; Tonascia JA
    N Engl J Med; 1973 Mar; 288(11):551-4. PubMed ID: 4685452
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral contraceptive use and fibrocystic breast disease with special reference to its histopathology.
    Pastides H; Kelsey JL; LiVolsi VA; Holford TR; Fischer DB; Goldenberg IS
    J Natl Cancer Inst; 1983 Jul; 71(1):5-9. PubMed ID: 6575209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case-control study of the epidemiology of benign breast diseases with reference to oral contraceptive use.
    Kelsey JL; Lindfors KK; White C
    Int J Epidemiol; 1974 Dec; 3(4):333-40. PubMed ID: 4435984
    [No Abstract]   [Full Text] [Related]  

  • 13. [Oral contraceptives and risk of benign tumors of the breast: recent data from the literature].
    Simard A
    Union Med Can; 1977 Aug; 106(8):1115-9. PubMed ID: 333686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weighing the evidence on the pill and breast cancer.
    Johnson JH
    Fam Plann Perspect; 1989; 21(2):89-92. PubMed ID: 2653859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Permanent alterations induced in plasma prolactin and estrogen receptor concentration in benign and malignant tissue of women who started oral contraceptive use at an early age.
    Olsson H; Lindahl B; Ranstam J; Borg A; Fernö M; Norgren A
    Anticancer Res; 1987; 7(4B):853-6. PubMed ID: 3674773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral contraceptives and venous thromboembolic disease, surgically confirmed gallbladder disease, and breast tumours. Report from the Boston Collaborative Drug Surveillance Programme.
    Lancet; 1973 Jun; 1(7817):1399-404. PubMed ID: 4126154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral contraceptives and breast neoplasia: a retrospective study.
    Vessey MP; Doll R; Sutton PM
    Br Med J; 1972 Sep; 3(5829):719-24. PubMed ID: 5077908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral contraception and breast pathology.
    Ragni N; Boccardo E; Viglino S; Larosa E
    Acta Eur Fertil; 1981 Jun; 12(2):141-63. PubMed ID: 6794288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral contraceptives and breast disease. An epidemiological study.
    Kelsey JL; Holford TR; White C; Mayer ES; Kilty SE; Acheson RM
    Am J Epidemiol; 1978 Mar; 107(3):236-44. PubMed ID: 629261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What do women use when they stop using the pill?
    Pratt WF; Bachrach CA
    Fam Plann Perspect; 1987; 19(6):257-66. PubMed ID: 3436413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.